Qiankun Xie

1.7k total citations
31 papers, 1.1k citations indexed

About

Qiankun Xie is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Qiankun Xie has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 8 papers in Surgery and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Qiankun Xie's work include Cancer Immunotherapy and Biomarkers (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers) and Genetic factors in colorectal cancer (6 papers). Qiankun Xie is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers) and Genetic factors in colorectal cancer (6 papers). Qiankun Xie collaborates with scholars based in China and Hong Kong. Qiankun Xie's co-authors include Ming Zhao, Ning Lyu, Shaolong Li, Luwen Mu, Haijing Deng, Wenzhuo He, Chang Jiang, Lin Yang, Pengfei Kong and Zhenfeng Zhang and has published in prestigious journals such as Journal of Hepatology, British Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Qiankun Xie

31 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiankun Xie China 17 483 385 274 208 200 31 1.1k
Joerg Trojan Germany 14 310 0.6× 321 0.8× 211 0.8× 253 1.2× 175 0.9× 30 946
Li‐Jian Liang China 17 474 1.0× 535 1.4× 250 0.9× 88 0.4× 133 0.7× 33 986
Fabrício Henrique Pereira De Souza United States 6 218 0.5× 648 1.7× 225 0.8× 195 0.9× 112 0.6× 8 950
Wen‐Feng Gong China 14 324 0.7× 800 2.1× 277 1.0× 140 0.7× 156 0.8× 29 1.1k
Yi‐Peng Fu China 17 389 0.8× 176 0.5× 180 0.7× 43 0.2× 177 0.9× 32 816
Kohei Nakachi Japan 18 970 2.0× 324 0.8× 831 3.0× 203 1.0× 659 3.3× 51 1.7k
Nathalie Guedj France 17 523 1.1× 286 0.7× 498 1.8× 150 0.7× 211 1.1× 52 1.3k
Shozo Mori Japan 11 288 0.6× 139 0.4× 140 0.5× 241 1.2× 201 1.0× 63 688
Dulabh Monga United States 15 539 1.1× 158 0.4× 277 1.0× 135 0.6× 227 1.1× 74 1.1k
Su Jung Shim South Korea 14 294 0.6× 228 0.6× 303 1.1× 247 1.2× 156 0.8× 34 819

Countries citing papers authored by Qiankun Xie

Since Specialization
Citations

This map shows the geographic impact of Qiankun Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiankun Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiankun Xie more than expected).

Fields of papers citing papers by Qiankun Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiankun Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiankun Xie. The network helps show where Qiankun Xie may publish in the future.

Co-authorship network of co-authors of Qiankun Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Qiankun Xie. A scholar is included among the top collaborators of Qiankun Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiankun Xie. Qiankun Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Xiaotong, Xin Dong, Kunyuan Wang, et al.. (2024). Radiotherapy enhances the anti-tumor effect of CAR-NK cells for hepatocellular carcinoma. Journal of Translational Medicine. 22(1). 929–929. 16 indexed citations
2.
He, Wenzhuo, et al.. (2024). Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer. British Journal of Cancer. 131(2). 334–346. 3 indexed citations
3.
Xu, Qiang, Qiankun Xie, Ruichen Gao, et al.. (2021). Risk factors and prevention of postoperative pancreatic fistula after insulinoma enucleation:a retrospective study from a high-volume center. Pancreatology. 21(6). 1208–1215. 15 indexed citations
4.
Deng, Haijing, Anna Kan, Ning Lyu, et al.. (2021). Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 9(6). e002305–e002305. 129 indexed citations
5.
Liu, Shousheng, Ning Lyu, Qiankun Xie, et al.. (2021). Effects of Antiviral Therapy on HBV Reactivation and Survival in Hepatocellular Carcinoma Patients Undergoing Hepatic Artery Infusion Chemotherapy. Frontiers in Oncology. 10. 582504–582504. 19 indexed citations
6.
Yang, Lin, Shousheng Liu, Zhenchong Xiong, et al.. (2020). Changes in colorectal cancer incidence by site and age from 1973 to 2015: a SEER database analysis. Aging Clinical and Experimental Research. 33(7). 1937–1946. 7 indexed citations
7.
Zhang, Baozhu, et al.. (2020). SPC25 overexpression promotes tumor proliferation and is prognostic of poor survival in hepatocellular carcinoma. Aging. 13(2). 2803–2821. 13 indexed citations
8.
Liu, Shousheng, Yuanzhong Yang, Chang Jiang, et al.. (2018). Comparison of immunological characteristics between paired mismatch repair-proficient and -deficient colorectal cancer patients. Journal of Translational Medicine. 16(1). 195–195. 16 indexed citations
9.
He, Wenzhuo, Wanming Hu, Pengfei Kong, et al.. (2018). Systemic neutrophil lymphocyte ratio and mismatch repair status in colorectal cancer patients: correlation and prognostic value. Journal of Cancer. 9(17). 3093–3100. 22 indexed citations
10.
Mu, Luwen, Tao Pan, Ning Lyu, et al.. (2018). CT-guided percutaneous radiofrequency ablation for lung neoplasms adjacent to the pericardium. Lung Cancer. 122. 25–31. 12 indexed citations
11.
He, Wenzhuo, Qiankun Xie, Wanming Hu, et al.. (2018). An increased number of negative lymph nodes is associated with a higher immune response and longer survival in colon cancer patients. Cancer Management and Research. Volume 10. 1597–1604. 15 indexed citations
12.
Yang, Lin, Wenzhuo He, Qiankun Xie, et al.. (2018). Brain metastases in newly diagnosed colorectal cancer: a population-based study. Cancer Management and Research. Volume 10. 5649–5658. 13 indexed citations
13.
Xie, Qiankun, Ping Chen, Wanming Hu, et al.. (2018). The systemic immune-inflammation index is an independent predictor of survival for metastatic colorectal cancer and its association with the lymphocytic response to the tumor. Journal of Translational Medicine. 16(1). 273–273. 94 indexed citations
14.
15.
He, Wenzhuo, Qiuxia Yang, Jinye Xie, et al.. (2018). Association of low skeletal muscle index with increased systematic inflammatory responses and interferon γ-induced protein 10 levels in patients with colon cancer. Cancer Management and Research. Volume 10. 2499–2507. 5 indexed citations
16.
Xie, Qiankun, Wenzhuo He, Wanming Hu, et al.. (2018). Tumor-infiltrating lymphocyte as a prognostic biomarker in stage IV colorectal cancer should take into account the metastatic status and operation modality. Cancer Management and Research. Volume 10. 1365–1375. 18 indexed citations
17.
18.
19.
Xie, Qiankun, Tao Pan, Ning Lyu, et al.. (2016). Programmed death ligand 1 as an indicator of pre-existing adaptive immune responses in human hepatocellular carcinoma. OncoImmunology. 5(7). e1181252–e1181252. 49 indexed citations
20.
Pan, Tao, et al.. (2014). Safety and efficacy of transarterial chemoembolization plus sorafenib for hepatocellular carcinoma with portal venous tumour thrombus. Clinical Radiology. 69(12). e553–e561. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joerg Trojan Breakdown of academic impact, for papers by Li‐Jian Liang Breakdown of academic impact, for papers by Fabrício Henrique Pereira De Souza Breakdown of academic impact, for papers by Wen‐Feng Gong Breakdown of academic impact, for papers by Yi‐Peng Fu Breakdown of academic impact, for papers by Kohei Nakachi Breakdown of academic impact, for papers by Nathalie Guedj Breakdown of academic impact, for papers by Shozo Mori Breakdown of academic impact, for papers by Dulabh Monga Breakdown of academic impact, for papers by Su Jung Shim
Rankless by CCL
2026